Leavell Investment Management Inc. acquired a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM – Free Report) during the 2nd quarter, HoldingsChannel reports. The fund acquired 4,484 shares of the company’s stock, valued at approximately $285,000.
A number of other hedge funds have also modified their holdings of TEM. Wealth Enhancement Advisory Services LLC acquired a new stake in Tempus AI during the first quarter worth about $440,000. Janney Montgomery Scott LLC purchased a new position in shares of Tempus AI in the first quarter valued at approximately $416,000. Cambridge Investment Research Advisors Inc. purchased a new position in Tempus AI in the first quarter worth approximately $1,019,000. Spire Wealth Management purchased a new position in Tempus AI in the first quarter worth approximately $69,000. Finally, Bartlett & CO. Wealth Management LLC lifted its stake in Tempus AI by 100.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company’s stock worth $39,000 after acquiring an additional 400 shares during the last quarter. 24.22% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
TEM has been the topic of a number of research analyst reports. Morgan Stanley raised their price objective on shares of Tempus AI from $65.00 to $68.00 and gave the stock an “overweight” rating in a report on Tuesday, August 12th. Needham & Company LLC reissued a “buy” rating and issued a $70.00 price objective on shares of Tempus AI in a research note on Friday, August 8th. Guggenheim boosted their target price on shares of Tempus AI from $80.00 to $95.00 and gave the stock a “buy” rating in a research report on Friday, September 26th. BTIG Research boosted their price objective on shares of Tempus AI from $85.00 to $96.00 and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Finally, HC Wainwright boosted their price objective on shares of Tempus AI from $90.00 to $98.00 and gave the stock a “buy” rating in a research report on Friday, September 12th. Seven research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $79.38.
Insider Transactions at Tempus AI
In other Tempus AI news, EVP Andrew Polovin sold 5,398 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $402,960.70. Following the completion of the transaction, the executive vice president owned 132,056 shares in the company, valued at $9,857,980.40. This represents a 3.93% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO James William Rogers sold 7,528 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $561,965.20. Following the completion of the transaction, the chief financial officer owned 138,473 shares of the company’s stock, valued at approximately $10,337,009.45. This represents a 5.16% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 767,412 shares of company stock worth $57,618,856 over the last 90 days. 26.27% of the stock is owned by corporate insiders.
Tempus AI Stock Up 2.6%
TEM opened at $91.58 on Tuesday. The firm has a 50 day moving average price of $84.46 and a 200 day moving average price of $68.38. The company has a market cap of $15.91 billion, a PE ratio of -76.96 and a beta of 4.87. Tempus AI, Inc. has a 1 year low of $31.36 and a 1 year high of $104.32. The company has a debt-to-equity ratio of 2.58, a quick ratio of 1.43 and a current ratio of 1.54.
Tempus AI (NASDAQ:TEM – Get Free Report) last released its quarterly earnings results on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.01. The firm had revenue of $314.64 million during the quarter, compared to analysts’ expectations of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.Tempus AI’s quarterly revenue was up 89.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($6.86) EPS. Tempus AI has set its FY 2025 guidance at EPS. Sell-side analysts expect that Tempus AI, Inc. will post -6.15 earnings per share for the current year.
Tempus AI Profile
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Featured Stories
- Five stocks we like better than Tempus AI
- The How And Why of Investing in Oil Stocks
- Growth Picks: 3 Low-Cost Stocks That Could Double in Value
- What Are Some of the Best Large-Cap Stocks to Buy?
- Are These 3 Beaten-Down Stocks Ready to Rebound?
- How to Most Effectively Use the MarketBeat Earnings Screener
- Does the Trump-Induced Quantum Stock Rally Have Legs?
Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM – Free Report).
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.
